URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Stephen Ettinghausen

TitleClinical Professor
InstitutionSchool of Medicine and Dentistry
DepartmentSurgery
AddressRochester General Hospital
1425 Portland Avenue
Department of Surgery
Rochester NY 14621
 
 Selected Publications
List All   |   Timeline
  1. Kovach SJ, Fischer AC, Katzman PJ, Salloum RM, Ettinghausen SE, Madeb R, Koniaris LG. Inflammatory myofibroblastic tumors. J Surg Oncol. 2006 Oct 1; 94(5):385-91.
    View in: PubMed
  2. Elaraj DM, Ettinghausen SE. Cytological analysis of peritoneal washings: now part of the standard preoperative staging evaluation for patients with resectable gastric cancer? Ann Surg Oncol. 2005 May; 12(5):339-41.
    View in: PubMed
  3. Jacquet P, Stephens AD, Averbach AM, Chang D, Ettinghausen SE, Dalton RR, Steves MA, Sugarbaker PH. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer. 1996 Jun 15; 77(12):2622-9.
    View in: PubMed
  4. Sugarbaker PH, Ronnett BM, Archer A, Averbach AM, Bland R, Chang D, Dalton RR, Ettinghausen SE, Jacquet P, Jelinek J, Koslowe P, Kurman RJ, Shmookler B, Stephens AD, Steves MA, Stuart OA, White S, Zahn CM, Zoetmulder FA. Pseudomyxoma peritonei syndrome. Adv Surg. 1996; 30:233-80.
    View in: PubMed
  5. Ettinghausen SE, Averbach AM. Adjuvant hyperthermic intraperitoneal chemotherapy for adenocarcinoma of the pancreas. Cancer Treat Res. 1996; 81:227-37.
    View in: PubMed
  6. Ettinghausen SE, Schwartzentruber DJ, Sindelar WF. Evolving strategies for the treatment of adenocarcinoma of the pancreas. A review. J Clin Gastroenterol. 1995 Jul; 21(1):48-60.
    View in: PubMed
  7. Ettinghausen SE, Rosenberg SA. Immunotherapy and gene therapy of cancer. Adv Surg. 1995; 28:223-54.
    View in: PubMed
  8. Theodossiou C, Kroog G, Ettinghausen S, Tolcher A, Cowan K, O'Shaughnessy J. Acute arterial thrombosis in a patient with breast cancer after chemotherapy with 5-fluorouracil, doxorubicin, leucovorin, cyclophosphamide, and interleukin-3. Cancer. 1994 Nov 15; 74(10):2808-10.
    View in: PubMed
  9. Yang JC, Topalian SL, Parkinson D, Schwartzentruber DJ, Weber JS, Ettinghausen SE, White DE, Steinberg SM, Cole DJ, Kim HI, et al. Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: an interim report. J Clin Oncol. 1994 Aug; 12(8):1572-6.
    View in: PubMed
  10. Cole DJ, Ettinghausen SE, Pass HI, Danforth DN, Linehan MW, Myers CW, Cooper MR, Sindelar WF. Postoperative complications in patients receiving suramin therapy. Surgery. 1994 Jul; 116(1):90-5.
    View in: PubMed
  11. Weber J, Gunn H, Yang J, Parkinson D, Topalian S, Schwartzentruber D, Ettinghausen S, Levitt D, Rosenberg SA. A phase I trial of intravenous interleukin-6 in patients with advanced cancer. J Immunother Emphasis Tumor Immunol. 1994 May; 15(4):292-302.
    View in: PubMed
  12. Marincola FM, Ettinghausen S, Cohen PA, Cheshire LB, Restifo NP, Mulé JJ, Rosenberg SA. Treatment of established lung metastases with tumor-infiltrating lymphocytes derived from a poorly immunogenic tumor engineered to secrete human TNF-alpha. J Immunol. 1994 Apr 1; 152(7):3500-13.
    View in: PubMed
  13. Cole DJ, Sanda MG, Yang JC, Schwartzentruber DJ, Weber J, Ettinghausen SE, Pockaj BA, Kim HI, Levin RD, Pogrebniak HW, et al. Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancer. J Natl Cancer Inst. 1994 Jan 5; 86(1):39-45.
    View in: PubMed
  14. Ettinghausen SE. Collagenous colitis, eosinophilic colitis, and neutropenic colitis. Surg Clin North Am. 1993 Oct; 73(5):993-1016.
    View in: PubMed
  15. Rosenberg SA, Anderson WF, Blaese M, Hwu P, Yannelli JR, Yang JC, Topalian SL, Schwartzentruber DJ, Weber JS, Ettinghausen SE, et al. The development of gene therapy for the treatment of cancer. Ann Surg. 1993 Oct; 218(4):455-63; discussion 463-4.
    View in: PubMed
  16. Weber J, Yang JC, Topalian SL, Parkinson DR, Schwartzentruber DS, Ettinghausen SE, Gunn H, Mixon A, Kim H, Cole D, et al. Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J Clin Oncol. 1993 Mar; 11(3):499-506.
    View in: PubMed
  17. Ettinghausen SE, Burt ME. Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. J Clin Oncol. 1991 Aug; 9(8):1462-6.
    View in: PubMed
  18. Ettinghausen SE, Puri RK, Rosenberg SA. Increased vascular permeability in organs mediated by the systemic administration of lymphokine-activated killer cells and recombinant interleukin-2 in mice. J Natl Cancer Inst. 1988 Apr 6; 80(3):177-88.
    View in: PubMed
  19. Ettinghausen SE, Moore JG, White DE, Platanias L, Young NS, Rosenberg SA. Hematologic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients. Blood. 1987 Jun; 69(6):1654-60.
    View in: PubMed
  20. Lotze MT, Matory YL, Rayner AA, Ettinghausen SE, Vetto JT, Seipp CA, Rosenberg SA. Clinical effects and toxicity of interleukin-2 in patients with cancer. Cancer. 1986 Dec 15; 58(12):2764-72.
    View in: PubMed
  21. Ettinghausen SE, Bonow RO, Palmeri ST, Seipp CA, Steinberg SM, White DE, Rosenberg SA. Prospective study of cardiomyopathy induced by adjuvant doxorubicin therapy in patients with soft-tissue sarcomas. Arch Surg. 1986 Dec; 121(12):1445-51.
    View in: PubMed
  22. Papa MZ, Vetto JT, Ettinghausen SE, Mulé JJ, Rosenberg SA. Effect of corticosteroid on the antitumor activity of lymphokine-activated killer cells and interleukin 2 in mice. Cancer Res. 1986 Nov; 46(11):5618-23.
    View in: PubMed
  23. Rosenstein M, Ettinghausen SE, Rosenberg SA. Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2. J Immunol. 1986 Sep 1; 137(5):1735-42.
    View in: PubMed
  24. Ettinghausen SE, Rosenberg SA. Immunotherapy of murine sarcomas using lymphokine activated killer cells: optimization of the schedule and route of administration of recombinant interleukin-2. Cancer Res. 1986 Jun; 46(6):2784-92.
    View in: PubMed
  25. Mulé JJ, Ettinghausen SE, Spiess PJ, Shu S, Rosenberg SA. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy. Cancer Res. 1986 Feb; 46(2):676-83.
    View in: PubMed
  26. Ettinghausen SE, Rosenberg SA. The adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2. Springer Semin Immunopathol. 1986; 9(1):51-71.
    View in: PubMed
  27. Rosenberg SA, Lotze MT, Muul LM, Leitman S, Chang AE, Ettinghausen SE, Matory YL, Skibber JM, Shiloni E, Vetto JT, et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med. 1985 Dec 5; 313(23):1485-92.
    View in: PubMed
  28. Ettinghausen SE, Lipford EH, Mulé JJ, Rosenberg SA. Recombinant interleukin 2 stimulates in vivo proliferation of adoptively transferred lymphokine-activated killer (LAK) cells. J Immunol. 1985 Nov; 135(5):3623-35.
    View in: PubMed
  29. Lotze MT, Matory YL, Ettinghausen SE, Rayner AA, Sharrow SO, Seipp CA, Custer MC, Rosenberg SA. In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2. J Immunol. 1985 Oct; 135(4):2865-75.
    View in: PubMed
  30. Ettinghausen SE, Lipford EH, Mulé JJ, Rosenberg SA. Systemic administration of recombinant interleukin 2 stimulates in vivo lymphoid cell proliferation in tissues. J Immunol. 1985 Aug; 135(2):1488-97.
    View in: PubMed
  31. Norton JA, Sigel B, Baker AR, Ettinghausen SE, Shawker TH, Krudy AG, Doppman JL, Taylor SI, Gordon P. Localization of an occult insulinoma by intraoperative ultrasonography. Surgery. 1985 Mar; 97(3):381-4.
    View in: PubMed
  32. Li TC, Reed CE, Stubenbord WT, Ettinghausen S, Peterson CM, Jovanovic L, Poffenbarger PL. Surgical cure of hypoglycemia associated with cystosarcoma phyllodes and elevated nonsuppressible insulin-like protein. Am J Med. 1983 Jun; 74(6):1080-4.
    View in: PubMed
  33. Ettinghausen SE, Pearlman SH, Brandstetter RD. Tricuspid valve erosion from Swan-Ganz catheters. Chest. 1981 Oct; 80(4):509-10.
    View in: PubMed
  34. Peretz WL, Ettinghausen SE, Gray GF. Oncocytic adenocarcinoma of the lacrimal sac. Arch Ophthalmol. 1978 Feb; 96(2):303-4.
    View in: PubMed

Visualizations


Ettinghausen's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department